Nanoparticle-mediated delivery of LGALS3BP exhibited anti-metastatic and antitumor effects, reducing TAK1 phosphorylation and MMP9 expression in TNBC primary tumor tissues. This evidence concerns the gene LGALS3BP and neoplasm.